Fossil (605318.SH) plans to invest in setting up Beichen Star Dome (Beijing) Technology Co., Ltd.

Chinatimes Financial News App News, Fosun Pharma (605318.SH) announced that the company plans to invest in the establishment of a wholly-owned subsidiary, Beijing Beichen Xingqiong Technology Co., Ltd. (tentative name), with a registered capital of 2.5 billion yuan. The establishment of this wholly-owned subsidiary is based on the company's development strategy to create a new platform for business transformation and new business development, in line with the company's long-term planning and the interests of all shareholders.